THU-146-LDV/SOF/RBV is an effective first-line DAA regimen as well as retreatment option for RF1_2k/1b patients within Georgian national hepatitis C elimination programMarika Karchava,Nikoloz Chkhartishvili,Lali Sharvadze,Akaki Abutidze,Natia Dvali,Lana Gatserelia,Lela Dzigua,Natalia Bolokadze,Adam Kotorashvili,Paata Imnadze,Amiran Gamkrelidze,Tengiz TsertsvadzeJOURNAL OF HEPATOLOGY（2019）引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
